Back
RxSight 10K Form
Buy
64
RXST
RxSight
Last Price:
60.70
Seasonality Move:
19.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RXST News And Ratings
See the #1 stock for the next 7 days that we like better than RXST
RXST Financial Statistics
Sales & Book Value
| Annual Sales: | $89.08M |
|---|---|
| Cash Flow: | $-11.28M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.41 |
| Price / Book: | 13.76 |
Profitability
| EPS (TTM): | -1.25000 |
|---|---|
| Net Income (TTM): | $-44.5M |
| Gross Margin: | $53.77M |
| Return on Equity: | -28.24% |
| Return on Assets: | -23.53% |
RxSight Earnings Forecast
Key RxSight Financial Ratios
- The Gross Profit Margin over the past 5 years for RXST is 60.36%.
- The Selling, General & Administrative Expenses for RXST have been equal to 83.97% of Gross Profit Margin.
- The Research & Development expenses have been 32.61% of Revenue.
- The Interest Expense is -6.81% of Operating Income.
- The Net Earning history of RXST is -54.57% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 2 years.
RxSight Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | RXST |
| Website: | rxsight.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 9.2 |
| Quick Ratio: | 8.02 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 659.24 |